Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...

She suggested I start taking the GLP-1 Zepbound through weekly injections, along with incorporating a healthy diet and ...

TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...

The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options. Blockbuster obesity and diabetes drugs — such as Wegovy, ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. GLP-1 ...